dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Miguel-Huguet, Bernat |
dc.contributor.author | Perez-Garcia, Jose Manuel |
dc.contributor.author | Llombart-Cussac, Antonio |
dc.contributor.author | Cortés Castan, Javier |
dc.contributor.author | Pérez López, Jorge |
dc.contributor.author | Sampayo-Cordero, Miguel |
dc.contributor.author | Malfettone, Andrea |
dc.date.accessioned | 2021-09-01T10:44:29Z |
dc.date.available | 2021-09-01T10:44:29Z |
dc.date.issued | 2020-09-10 |
dc.identifier.citation | Sampayo-Cordero M, Miguel-Huguet B, Malfettone A, Pérez-García JM, Llombart-Cussac A, Cortés J, et al. The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II). Int J Environ Res Public Health. 2020 Sep 10;17(18):6590. |
dc.identifier.issn | 1660-4601 |
dc.identifier.uri | https://hdl.handle.net/11351/6249 |
dc.description | Informe d'un cas; Malaltia rara; Revisió sistemàtica |
dc.description.sponsorship | This research received no external funding. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | International Journal Of Environmental Research And Public Health;17(18) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Malalties rares |
dc.subject | Malalties congènites |
dc.subject | Enzims - Ús terapèutic |
dc.subject.mesh | Enzyme Replacement Therapy |
dc.subject.mesh | Mucopolysaccharidosis II |
dc.subject.mesh | Rare Diseases |
dc.title | The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/ijerph17186590 |
dc.subject.decs | tratamiento de sustitución enzimática |
dc.subject.decs | mucopolisacaridosis II |
dc.subject.decs | enfermedades raras |
dc.relation.publishversion | https://www.mdpi.com/1660-4601/17/18/6590 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Sampayo-Cordero M, Malfettone A] Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. [Miguel-Huguet B] Department of Surgery, Hospital de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain. [Pérez-García JM] Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. Institute of Breast Cancer, Quiron Group, Barcelona, Spain. [Llombart-Cussac A] Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. Hospital Arnau de Vilanova, Universidad Católica de Valencia “San Vicente Mártir”, Valencia, Spain. [Cortés J] Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. Institute of Breast Cancer, Quiron Group, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Pérez-López J] Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 32927819 |
dc.identifier.wos | 000580345000001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |